Skip Navigation Skip to main content
  • Warning Signs
  • Volunteer
  • Donate
return to American Heart Association Newsroom
  • Heart Attack And Stroke Symptoms
  • Volunteer
  • Donate
Newsroom
    • News Media Embargoed Access
    • Login to Password Protected Newsroom
    • Apply for Embargoed Access
    • Embargo Policy and Guidelines
    • American Heart Association Fact Sheets
    • Boilerplates
    • Copyright Permissions
    • Glossary of Scientific Terms
    • Linking Policy
    • Scientific Statements/Guidelines
    • Scientific Publications: Purposes-Processes
    • Statistics
    • Multimedia Resources
    • Animation/Video
    • Images/Graphics
    • Audio
    • Usage Policy
    • Connect With Us
    • Media Contacts
    • Consumer/Media Connections
  • Twitter
  • Facebook
  • YouTube
  • RSS
  • Email Alerts
  1. Newsroom
  2. Search News Releases
  3. Data analysis finds multiple antiplatelets linked to worse outcomes after a brain bleed
Categories: Scientific Conferences & Meetings, Stroke News & Brain Health
|
Published: January 29, 2026

Data analysis finds multiple antiplatelets linked to worse outcomes after a brain bleed

American Stroke Association International Stroke Conference 2026, Abstract A146
facebook Facebook
twitter Twitter
facebook LinkedIn
facebook Email
facebook Print

Related Images

Previous Slide Next Slide

Organs in the body - transparent illustration

Heart disease is the Number 1 killer in the United States.

Brain, right lung, left lung, heart, right kidney, left kidney.

Watch, Learn, and Live Library

copyright American Heart Association

Download (354.8 kB)
Organs in the body - transparent illustration

Organs in the body - transparent illustration

Heart disease is the Number 1 killer in the United States.

Brain, right lung, left lung, heart, right kidney, left kidney.

Watch, Learn, and Live Library

copyright American Heart Association


Please see AHA/ASA Multimedia Materials Usage Policy.

Download (354.8 kB) File Permalink

Santosh Murthy, M.D., M.P.H.

Santosh Murthy, M.D., M.P.H., an associate professor of neurology and neuroscience at Weill Cornell Medicine in New York City

copyright Weill Cornell Medicine

Download (4.7 MB)
Santosh Murthy, M.D., M.P.H.

Santosh Murthy, M.D., M.P.H.

Santosh Murthy, M.D., M.P.H., an associate professor of neurology and neuroscience at Weill Cornell Medicine in New York City

copyright Weill Cornell Medicine


Please see AHA/ASA Multimedia Materials Usage Policy.

Download (4.7 MB) File Permalink

ISC Logo

copyright American Stroke Association

Download (62.9 kB)
ISC Logo

ISC Logo

copyright American Stroke Association


Please see AHA/ASA Multimedia Materials Usage Policy.

Download (62.9 kB) File Permalink
  • Organs in the body - transparent illustration
  • Santosh Murthy, M.D., M.P.H.
  • ISC Logo

Related Video

Previous Slide Next Slide

Dr. Rosand on ISC26 A146 exciting aspects of study

American Stroke Association volunteer expert, Jonathan Rosand, M.D., M.Sc., FAHA, is a professor of neurology at Harvard, holds the JP Kistler Endowed Chair in Neurology at Massachusetts General Hospital and is founder of the Global Brain Care Coalition. He was not involved in this study.

Transcript

News release

copyright American Heart Association

Download (91.3 MB)
Sorry, your browser doesn\'t support embedded videos, download and watch with your favorite video player!

Dr. Rosand on ISC26 A146 exciting aspects of study

American Stroke Association volunteer expert, Jonathan Rosand, M.D., M.Sc., FAHA, is a professor of neurology at Harvard, holds the JP Kistler Endowed Chair in Neurology at Massachusetts General Hospital and is founder of the Global Brain Care Coalition. He was not involved in this study.

Transcript

News release

copyright American Heart Association


Please see AHA/ASA Multimedia Materials Usage Policy.

Download (91.3 MB) File Permalink

Dr. Rosand on ISC26 A146 patients on antiplatelet therapies

American Stroke Association volunteer expert, Jonathan Rosand, M.D., M.Sc., FAHA, is a professor of neurology at Harvard, holds the JP Kistler Endowed Chair in Neurology at Massachusetts General Hospital and is founder of the Global Brain Care Coalition. He was not involved in this study.

Transcript

News release

copyright American Heart Association

Download (66.9 MB)
Sorry, your browser doesn\'t support embedded videos, download and watch with your favorite video player!

Dr. Rosand on ISC26 A146 patients on antiplatelet therapies

American Stroke Association volunteer expert, Jonathan Rosand, M.D., M.Sc., FAHA, is a professor of neurology at Harvard, holds the JP Kistler Endowed Chair in Neurology at Massachusetts General Hospital and is founder of the Global Brain Care Coalition. He was not involved in this study.

Transcript

News release

copyright American Heart Association


Please see AHA/ASA Multimedia Materials Usage Policy.

Download (66.9 MB) File Permalink

Dr. Rosand on ISC26 A146 monitoring stroke warning signs

American Stroke Association volunteer expert, Jonathan Rosand, M.D., M.Sc., FAHA, is a professor of neurology at Harvard, holds the JP Kistler Endowed Chair in Neurology at Massachusetts General Hospital and is founder of the Global Brain Care Coalition. He was not involved in this study.

Transcript

News release

copyright American Heart Association

Download (40.2 MB)
Sorry, your browser doesn\'t support embedded videos, download and watch with your favorite video player!

Dr. Rosand on ISC26 A146 monitoring stroke warning signs

American Stroke Association volunteer expert, Jonathan Rosand, M.D., M.Sc., FAHA, is a professor of neurology at Harvard, holds the JP Kistler Endowed Chair in Neurology at Massachusetts General Hospital and is founder of the Global Brain Care Coalition. He was not involved in this study.

Transcript

News release

copyright American Heart Association


Please see AHA/ASA Multimedia Materials Usage Policy.

Download (40.2 MB) File Permalink

Dr. Rosand on ISC26 A146 benefits of antiplatelet therapies

American Stroke Association volunteer expert, Jonathan Rosand, M.D., M.Sc., FAHA, is a professor of neurology at Harvard, holds the JP Kistler Endowed Chair in Neurology at Massachusetts General Hospital and is founder of the Global Brain Care Coalition. He was not involved in this study.

Transcript

News release

copyright American Heart Association

Download (41.0 MB)
Sorry, your browser doesn\'t support embedded videos, download and watch with your favorite video player!

Dr. Rosand on ISC26 A146 benefits of antiplatelet therapies

American Stroke Association volunteer expert, Jonathan Rosand, M.D., M.Sc., FAHA, is a professor of neurology at Harvard, holds the JP Kistler Endowed Chair in Neurology at Massachusetts General Hospital and is founder of the Global Brain Care Coalition. He was not involved in this study.

Transcript

News release

copyright American Heart Association


Please see AHA/ASA Multimedia Materials Usage Policy.

Download (41.0 MB) File Permalink

Dr. Rosand on ISC26 A146 antiplatelet therapies study implications

American Stroke Association volunteer expert, Jonathan Rosand, M.D., M.Sc., FAHA, is a professor of neurology at Harvard, holds the JP Kistler Endowed Chair in Neurology at Massachusetts General Hospital and is founder of the Global Brain Care Coalition. He was not involved in this study.

Transcript

News release

copyright American Heart Association

Download (45.8 MB)
Sorry, your browser doesn\'t support embedded videos, download and watch with your favorite video player!

Dr. Rosand on ISC26 A146 antiplatelet therapies study implications

American Stroke Association volunteer expert, Jonathan Rosand, M.D., M.Sc., FAHA, is a professor of neurology at Harvard, holds the JP Kistler Endowed Chair in Neurology at Massachusetts General Hospital and is founder of the Global Brain Care Coalition. He was not involved in this study.

Transcript

News release

copyright American Heart Association


Please see AHA/ASA Multimedia Materials Usage Policy.

Download (45.8 MB) File Permalink

Dr. Rosand on ISC26 A146 antiplatelet therapies explained

American Stroke Association volunteer expert, Jonathan Rosand, M.D., M.Sc., FAHA, is a professor of neurology at Harvard, holds the JP Kistler Endowed Chair in Neurology at Massachusetts General Hospital and is founder of the Global Brain Care Coalition. He was not involved in this study.

Transcript

News release

copyright American Heart Association

Download (160.0 MB)
Sorry, your browser doesn\'t support embedded videos, download and watch with your favorite video player!

Dr. Rosand on ISC26 A146 antiplatelet therapies explained

American Stroke Association volunteer expert, Jonathan Rosand, M.D., M.Sc., FAHA, is a professor of neurology at Harvard, holds the JP Kistler Endowed Chair in Neurology at Massachusetts General Hospital and is founder of the Global Brain Care Coalition. He was not involved in this study.

Transcript

News release

copyright American Heart Association


Please see AHA/ASA Multimedia Materials Usage Policy.

Download (160.0 MB) File Permalink

Dr. Rosand on ISC26 A146 antiplatelet therapies and stroke risk

American Stroke Association volunteer expert, Jonathan Rosand, M.D., M.Sc., FAHA, is a professor of neurology at Harvard, holds the JP Kistler Endowed Chair in Neurology at Massachusetts General Hospital and is founder of the Global Brain Care Coalition. He was not involved in this study.

Transcript

News release

copyright American Heart Association

Download (118.2 MB)
Sorry, your browser doesn\'t support embedded videos, download and watch with your favorite video player!

Dr. Rosand on ISC26 A146 antiplatelet therapies and stroke risk

American Stroke Association volunteer expert, Jonathan Rosand, M.D., M.Sc., FAHA, is a professor of neurology at Harvard, holds the JP Kistler Endowed Chair in Neurology at Massachusetts General Hospital and is founder of the Global Brain Care Coalition. He was not involved in this study.

Transcript

News release

copyright American Heart Association


Please see AHA/ASA Multimedia Materials Usage Policy.

Download (118.2 MB) File Permalink
  • Dr. Rosand on ISC26 A146 exciting aspects of study
  • Dr. Rosand on ISC26 A146 patients on antiplatelet therapies
  • Dr. Rosand on ISC26 A146 monitoring stroke warning signs
  • Dr. Rosand on ISC26 A146 benefits of antiplatelet therapies
  • Dr. Rosand on ISC26 A146 antiplatelet therapies study implications
  • Dr. Rosand on ISC26 A146 antiplatelet therapies explained
  • Dr. Rosand on ISC26 A146 antiplatelet therapies and stroke risk
AHA Logo
This link is provided for convenience only and is not an endorsement of either the linked-to entity or any product or service.
CLOSE PROCEED